The ResMed Share Price Up on Results (ASX:RMD)

By ,

San Diego-based healthcare company ResMed Inc [ASX:RMD] has seen a 16% increase in year-over-year revenue to $769.5 million. The ResMed share price is up 5.47% to $24.68 at the time of writing.

ASX RMD - ResMed Share Price Chart 1

Source: Optuma

The ResMed share price and COVID-19

As a global healthcare company, ResMed had a pre-coronavirus focus on the development, manufacturing, and distribution of sleep disorder respiratory machines. ResMed then pivoted their business to create ventilators in response to the COVID-19 virus pandemic currently gripping the world.

ResMed’s CEO, Mick Farrell, commented:

We are operating during unprecedented times, and I am extremely proud of the way our global ResMed team has responded to the COVID-19 crisis.

Our primary goals are the safety and wellbeing of our team members, and the preservation of life – helping people breathe while their immune system fights this coronavirus.

Future for ResMed share price

Noted in the results was that:

Revenue in the U.S., Canada, and Latin America, excluding Software as a Service, grew by 12% driven by strong sales across our mask and device product portfolios, including increased demand for our ventilators due to COVID-19.

This could bode well for ResMed in the current climate. Right now, in the US alone there are over one million cases of COVID-19 and more than 63,000 deaths, showing that now, more than ever, people need the products that companies like ResMed produce.

On the charts, ResMed is looking strong. Having fallen to a low of $18.10 in March, if momentum persists this may be the lowest ebb for some time, in my view. The ResMed share price has rebounded well, recording only a 12.03% loss in price from the all-time high in February 2020.

ASX RMD - ResMed Share Price Chart 2

Source: Optuma

As you can see, the ResMed share price has come down in the last week and seems to of found resistance at the historical level of $22.93, should if continue to fall, the level of $20.76 may come into focus. In the event of a move back to the upside, extension levels of $27.39, $28.56, and potentially $32.05 may come into play.

ASX RMD - ResMed Share Price Chart 3

Source: Optuma

If you want to learn about the two types of assets that could benefit from this new investing environment, download a free copy of ‘The Coronavirus Portfolio’. In it, my colleague Lachlann Tierney runs you through the kinds of investments he thinks have the most potential in the downturn.


Carl Wittkopp,
For Money Morning


About Carl Wittkopp

Carl Wittkopp writes for Money Morning and has a diploma in Financial Planning. He specialises in technical analysis.

RMD Shares Down: Market Open before Recouping Grounds (ASX:RMD)

Shares in Resmed CDI (ASX:RMD) are down 0.6% at time of writing, slipping as investors digest the medtech’s fourth quarter results.

Weekly ASX Market Wrap — WSA and SAR Top Movers Last Week

The previous week saw the ASX All Ordinaries [XAO] close at 6,011 points. The opening three days of the week saw trading move sideways before a drop on Thursday. Friday was a wild day of trading, with [XAO] eventually…

ResMed Share Price Rises on Another Strong Quarter (ASX: RMD)

The ResMed share price added $2.70 to their price within the first hour of trading — a 14.5% spike. Shares of global health company ResMed Inc [ASX:RMD, NYSE:RMD] will pique investor interest today as they announce their Q1 FY 2020 results…

ResMed Shares Climb 10% with Strong Q3 Results

World-leading connected health company ResMed Inc [ASX:RMD] is a frontrunner in today’s trading, with their shares up 10.4% at time of writing, to $16.34 per share.

ResMed Share Price Hits another Record High Ahead of Quarterly Report

Shares in ResMed Inc [ASX:RMD] are now sitting steady at $16.55, rising 1.16% today. This week saw the medical specialist group hit a record high in its share price ahead of the release of their Q2 results for 2019 — due Friday, 25 January